Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gastric Balloon-Makers Respond To US FDA Warning

Executive Summary

Apollo Endosurgery and Reshape Medical are both defending their products’ safety in the wake of a US FDA letter warning of five deaths tied to the companies' intragastric balloon devices.

Advertisement

Related Content

Gastric Balloon Labeling Updated After Patient Deaths
Market Intel: Intragastric Balloons And Other Innovations To Inflate Weight Loss Devices Market
EnteroMedics Inflates Neuromod-Obesity Offering With ReShape Balloon
US FDA Warns of Deaths Tied To Gastric Balloons
US FDA Warns Docs On Gastric Balloon Adverse Events

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT105309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel